Search research articles
Contact Us
Filters
Showing results (1-10 of 116) with videos related to
Page
of 12
Sort By:
Soins; La Revue De Reference Infirmiere
|
June 1, 2010
[Psychological care in cases of renal failure]
Céline Franchetto, Jean-Pierre Kahn
Substance Abuse
|
October 8, 2016
Acute effects of synthetic cannabinoids: Update 2015
Juliana Tournebize, Valérie Gibaja, Jean-Pierre Kahn
The American Journal on Addictions
|
March 14, 2009
Misuse of alcohol among methadone patients
Charles-Edouard Rengade, Jean-Pierre Kahn, Raymund Schwan
Soins; La Revue De Reference Infirmiere
|
April 17, 2017
[Suicide in adolescence]
Alexandra Tubiana, Renaud F Cohen, Jean-Pierre Kahn
Pain Practice : the Official Journal of World Institute of Pain
|
April 14, 2015
Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence
Juliana Tournebize, Valérie Gibaja, Amandine Muszczak, et al.
International Clinical Psychopharmacology
|
February 13, 2007
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
Max Schmauss, Emilio Sacchetti, Jean-Pierre Kahn, et al.
International Journal of Cardiology
|
November 1, 2015
Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report
Juliana Tournebize, Valérie Gibaja, Emmanuel Puskarczyk, et al.
Therapie
|
April 11, 2015
Signal identification in addictovigilance: the functioning of the French system
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, et al.
Therapie
|
November 6, 2018
[Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]
Pauline Barberot, Valérie Gibaja, Célia Benkhedda, et al.
International Journal of Psychiatry in Clinical Practice
|
June 19, 2014
Symptom control, functioning, and hospitalization status in French patients changed from oral atypical antipsychotics to risperidone long-acting injectable
Pierre-Michel Llorca, Jean-Pierre Kahn, Véronique Moreau-Mallet, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 116) with videos related to
Sort By:
Page
of 12
Soins; La Revue De Reference Infirmiere
|
June 1, 2010
[Psychological care in cases of renal failure]
Céline Franchetto, Jean-Pierre Kahn
Substance Abuse
|
October 8, 2016
Acute effects of synthetic cannabinoids: Update 2015
Juliana Tournebize, Valérie Gibaja, Jean-Pierre Kahn
The American Journal on Addictions
|
March 14, 2009
Misuse of alcohol among methadone patients
Charles-Edouard Rengade, Jean-Pierre Kahn, Raymund Schwan
Soins; La Revue De Reference Infirmiere
|
April 17, 2017
[Suicide in adolescence]
Alexandra Tubiana, Renaud F Cohen, Jean-Pierre Kahn
Pain Practice : the Official Journal of World Institute of Pain
|
April 14, 2015
Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence
Juliana Tournebize, Valérie Gibaja, Amandine Muszczak, et al.
International Clinical Psychopharmacology
|
February 13, 2007
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone
Max Schmauss, Emilio Sacchetti, Jean-Pierre Kahn, et al.
International Journal of Cardiology
|
November 1, 2015
Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report
Juliana Tournebize, Valérie Gibaja, Emmanuel Puskarczyk, et al.
Therapie
|
April 11, 2015
Signal identification in addictovigilance: the functioning of the French system
Emilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, et al.
Therapie
|
November 6, 2018
[Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)]
Pauline Barberot, Valérie Gibaja, Célia Benkhedda, et al.
International Journal of Psychiatry in Clinical Practice
|
June 19, 2014
Symptom control, functioning, and hospitalization status in French patients changed from oral atypical antipsychotics to risperidone long-acting injectable
Pierre-Michel Llorca, Jean-Pierre Kahn, Véronique Moreau-Mallet, et al.
Page
of 12